(19)

(11)

EP 3 980 069 A1

(12)

(43) Date of publication: 13.04.2022 Bulletin 2022/15 (21) Application number: 21738476.7 (22) Date of filing: 08.01.2021

(51) International Patent Classification (IPC):  A61K 39/395(2006.01) A61P 29/00(2006.01) A61K 48/00(2006.01) (52) Cooperative Patent Classification (CPC): A61P 29/00; A61K 31/4985; A61K 31/519 (86) International application number: PCT/US2021/012696 (87) International publication number: WO 2021/142257 (15.07.2021 Gazette 2021/28)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 08.01.2020 US 202062958632 P (60) Divisional application: 22150344.4 (71) Applicant: Telios Pharma, Inc. Redwood City, California 94065 (US)	(72) Inventor: ROTHBAUM, Wayne Philip New York, New York 10023 (US) (74) Representative: Gevers & Orès  Immeuble le Palatin 2 3 Cours du Triangle CS 80165 92939 Paris La Défense Cedex 92939 Paris La Défense Cedex (FR)